Home > Insider Trading > Filing (0000950170-24-105616)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1579428	Axsome Therapeutics Inc.	AXSM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1295913	E Mark Saad	C/O Axsome Therapeutics, Inc. One World Trade Center, 22Nd Floor New York NY 10007		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-09-11	11,016	$3.67	21,018	No	4	M	Direct
Common Stock	Disposition	2024-09-11	11,016	$91.31	10,002	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-09-11	11,016	$0.00	11,016	$3.67

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2015-09-16	2024-09-16	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	300	Indirect	See explanation 5 below.

Footnotes

Represents an exercise of stock options prior to the 10-year expiration date of such options, which would occur later this month.
Such transaction was pursuant to a pre-approved 10b5-1 plan.
Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $90.25 and $92.90.
Represents additional shares held indirectly by the Reporting Person prior to September 11, 2024 which includes shares indirectly beneficially owned by Mr. Saad as custodian for his children's UTMA accounts.